首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura.
【24h】

The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura.

机译:类固醇和静脉内免疫球蛋白对小儿免疫性血小板减少性紫癜患者血小板生成素水平的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Thrombopoietin (TPO), which is the main regulator of megakaryo/thrombopoiesis, has been recently cloned and purified, and shown to be useful in discriminating thrombocytopenia due to decreased production or increased platelet destruction. However, there are no detailed investigations about the drug effects on TPO levels during childhood. This study was conducted to measure the TPO levels of children with immune thrombocytopenic purpura (ITP) during steroid and immunoglobulin treatment. Twelve patients with acute ITP were treated with high-dose methyl prednisolone and five patients were treated with intravenous immunoglobulin. Neither steroids nor immunoglobulin were found to have any effect on TPO levels.
机译:血小板生成素(TPO)是巨核细胞/血小板生成的主要调节剂,最近已被克隆和纯化,由于产量减少或血小板破坏增加,显示出可用于区分血小板减少症。但是,目前尚无关于该药物对儿童期TPO水平的影响的详细调查。这项研究旨在测量类固醇和免疫球蛋白治疗期间免疫性血小板减少性紫癜(ITP)儿童的TPO水平。 12例急性ITP患者接受大剂量甲基泼尼松龙治疗,5例患者接受静脉免疫球蛋白治疗。类固醇和免疫球蛋白均未发现对TPO水平有任何影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号